Código QR (código de barras bidimensional)

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

Abstract A novel combination of capecitabine, oxaliplatin, and bevacizumab was evaluated in colorectal cancer patients enrolled in a phase II clinical trial. In this retrospective analysis, plasma samples from patients receiving capecitabine, oxaliplatin, and bevacizumab were analyzed to investigate...

ver descrição completa

Na minha lista:
Principais autores: Yingmiao Liu, Mark D. Starr, Anuradha Bulusu, Herbert Pang, Nan Soon Wong, Wanda Honeycutt, Anthony Amara, Herbert I. Hurwitz, Andrew B. Nixon
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2013-04-01
coleção:Cancer Medicine
Assuntos:
Angiome
bevacizumab
biomarker
chemotherapy
colorectal cancer
Acesso em linha:https://doi.org/10.1002/cam4.71
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados